版本:
中国

BRIEF-Onconova Therapeutics says entered market issuance sales agreement with FBR Capital

April 20 Onconova Therapeutics Inc:

* Onconova Therapeutics- on dec. 5, 2016, co entered into at market issuance sales agreement with FBR capital to create an at--market equity program

* Onconova Therapeutics Inc - effective april 19, 2017, company terminated sales agreement and related atm program - sec filing

* Onconova Therapeutics Inc - has decided to terminate sales agreement because it does not intend to utilize sales agreement to raise additional capital

* Onconova Therapeutics Inc - company will not incur any termination penalties as a result of its termination of sales agreement Source text - bit.ly/2p0N6Wx Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐